Profile
Michael Bolinder worked at Mallinckrodt Pharmaceuticals Ltd. from 2013 to 2015 as Head-Marketing & Commercial Strategy.
From 2015 to 2022, Mr. Bolinder was at Acacia Pharma Group Ltd., serving as Chief Executive Officer from 2019 to 2022.
Mr. Bolinder completed undergraduate education at Florida State University.
Former positions of Michael Bolinder
| Companies | Position | End |
|---|---|---|
| ACACIA PHARMA GROUP PLC | Chief Executive Officer | 01/06/2022 |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Sales & Marketing | 01/08/2015 |
Training of Michael Bolinder
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Group Ltd.
Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Mallinckrodt Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Michael Bolinder
















